Key terms
About EW
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest EW news
Nov 19
12:45pm ET
Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules
Nov 08
2:05pm ET
Edwards Lifesciences call volume above normal and directionally bullish
Oct 31
2:25pm ET
Edwards Lifesciences call volume above normal and directionally bullish
Oct 30
11:05am ET
Edwards Lifesciences Evoque demonstrated superiority vs. medical therapy alone
Oct 29
7:45am ET
Oppenheimer Keeps Their Buy Rating on Edwards Lifesciences (EW)
Oct 29
7:18am ET
Truist Financial Releases a Hold Rating on Edwards Lifesciences (EW)
Oct 29
6:46am ET
Hold Rating Maintained on Edwards Lifesciences Amid Uncertain Immediate Financial Impact of EARLY TAVR Trial Results
Oct 29
6:39am ET
Piper Sandler Reaffirms Their Hold Rating on Edwards Lifesciences (EW)
Oct 29
6:37am ET
Promising EARLY TAVR Trial Results Bolster Buy Rating for Edwards Lifesciences
Oct 29
6:25am ET
Hold Rating on Edwards Lifesciences Amid Uncertainties in TAVR Data
Oct 28
2:25pm ET
Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott
Oct 28
12:25pm ET
Edwards Lifesciences call volume above normal and directionally bullish
Oct 28
12:05pm ET
JPMorgan views Edwards Lifesciences TAVR data positively
Oct 28
11:45am ET
Promising EARLY TAVR Trial Results Boost Edwards Lifesciences’ Outlook with 16.7% Projected Share Price Growth
Oct 28
11:40am ET
Edwards Lifesciences TAVR data better than expected, says Citi
Oct 28
11:05am ET
Edwards Lifesciences announces results from EARLY TAVR trial
Oct 28
10:05am ET
Early notable gainers among liquid option names on October 28th
Oct 28
9:47am ET
Coinbase initiated, Edwards Lifesciences upgraded: Wall Street’s top analyst cal
Oct 28
6:25am ET
Edwards Lifesciences upgraded to Market Perform from Underperform at Bernstein
Oct 26
12:05pm ET
Edwards Lifesciences price target raised to $85 from $80 at Barclays
Oct 26
11:56am ET
Strong Growth and Promising Outlook: Buy Rating for Edwards Lifesciences
Oct 25
12:17pm ET
Edwards Lifesciences: Promising Growth in TAVR and TMTT Amidst Near-Term Uncertainties
Oct 25
11:16am ET
Edwards Lifesciences Faces Challenges Amidst TAVR Market Maturity and Rising Competition, Leading to Hold Rating
Oct 25
9:07am ET
Edwards Lifesciences price target lowered to $70 from $73 at Piper Sandler
Oct 25
8:55am ET
Edwards Lifesciences price target lowered to $70 from $71 at Truist
Oct 25
8:55am ET
Edwards Lifesciences price target raised to $63 from $60 at Canaccord
Oct 25
8:35am ET
Edwards Lifesciences (EW) Gets a Hold from Jefferies
Oct 25
8:05am ET
Edwards Lifesciences (EW) Gets a Buy from Oppenheimer
Oct 25
8:04am ET
Cautious Hold Rating for Edwards Lifesciences Amid Mixed Growth Prospects and Strategic Challenges
Oct 25
8:01am ET
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
Oct 25
7:53am ET
Hold Rating on Edwards Lifesciences Amidst Growth Constraints and Transition Year Projections
Oct 28
9:15am ET
International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors
Oct 25
9:25am ET
EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls
Oct 24
6:00pm ET
Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics
Oct 23
11:40am ET
TFX or EW: Which Is the Better Value Stock Right Now?
Oct 21
9:16am ET
Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Oct 20
6:10pm ET
RLF, Leading Investor Counsel, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW
Oct 20
11:00am ET
Edwards Lifesciences Corporation Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation
Oct 20
9:42am ET
EW Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
Oct 20
7:06am ET
EW LAWSUIT ALERT: Edwards Lifesciences Corporation Investors that Lost Money are Alerted to Contact BFA Law by December 13 Court Deadline
Oct 19
5:02pm ET
RLF, A Top Ranked Law Firm, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW
Oct 19
11:00am ET
Investors Are Encouraged To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
Oct 18
5:00pm ET
RLF, Global Investor Counsel, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW
Oct 18
11:00am ET
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Shareholder Participation
Oct 18
8:55am ET
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
Oct 18
7:11am ET
EW FRAUD NEWS: Investors who Suffered Losses on their Edwards Lifesciences Corporation Securities are Notified to Contact BFA Law before the December 13 Class Action Deadline
Oct 17
4:55pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW
Oct 17
11:00am ET
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
Oct 16
4:05pm ET
Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
Oct 16
4:00pm ET
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Oct 16
2:00pm ET
Lost Money on Edwards Lifesciences Corporation (EW)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Oct 16
1:45pm ET
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Oct 16
11:45am ET
Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
Oct 16
11:22am ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
Oct 16
11:00am ET
Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Shareholders With Losses To Take Part
Oct 16
8:00am ET
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for Investors - Contact Levi & Korsinsky
Oct 16
7:15am ET
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
Oct 16
6:50am ET
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
Oct 16
6:34am ET
EW LEGAL NEWS: Suffer Losses on Your Edwards Lifesciences Corporation Investment? Contact BFA Law before Expiration of Upcoming December 13 Deadline (EW)
Oct 16
12:24am ET
Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW
Oct 15
9:30pm ET
Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation(EW)
Oct 15
7:00pm ET
Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
EW Financials
Key terms
Ad Feedback
EW Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
EW Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
